Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases

Structure

Volumn 12, Issue 7, 2004, Pages 1325-1334

  Somoza, John R ^a   Skene, Robert J ^b   Katz, Bradley A ^a   Mol, Clifford ^b   Ho, Joseph D ^a   Jennings, Andy J ^b   Luong, Christine ^a   Arvai, Andrew ^b   Buggy, Joseph J ^a   Chi, Ellen ^b   Tang, Jie ^a   Sang, Bi Ching ^b   Verner, Erik ^a   Wynands, Robert ^b   Leahy, Ellen M ^a   Dougan, Douglas R ^b   Snell, Gyorgy ^b   Navre, Marc ^b   Knuth, Mark W ^b,c   Swanson, Ronald V ^b,c   McRee, Duncan E ^b,c   Tari, Leslie W ^b   more..

^a CELERA   (United States)

^b Takeda San Diego Inc   (United States)

^c ActiveSight   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING AGENT; HISTONE DEACETYLASE; HYDROXAMIC ACID; SERINE;

ANIMAL CELL; ARTICLE; CATALYSIS; CATALYST; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME SPECIFICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

AMINO ACID SEQUENCE; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; HISTONE DEACETYLASES; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; REPRESSOR PROTEINS; SUBSTRATE SPECIFICITY;

ANIMALIA;

EID: 3142562372     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2004.04.012     Document Type: Article

References (40)

1. Almenara J., Rosato R., Grant S. Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA). Leukemia. 16:2002;1331-1343
2. Ayer D.E. Histone deacetylases. transcriptional repression with SIN-ers and NuRDs Trends Cell Biol. 9:1999;193-198
3. Brünger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.-S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D. 54:1998;905-921
4. Buggy J.J., Sideris M.L., Mak P., Lorimer D.D., McIntosh B., Clark J.M. Cloning and characterization of a novel human histone deacetylase, HDAC8. Biochem. J. 350:2000;199-205
5. David G., Neptune M.A., DePinho R.A. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J. Biol. Chem. 277:2002;23658-23663
6. Durst K.L., Lutterbach B., Kummalue T., Friedman A.D., Hiebert S.W. The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain. Mol. Cell. Biol. 23:2003;607-619
7. Finnin M.S., Donigian J.R., Cohen A., Richon V.M., Rifkind R.A., Marks P.A., Breslow R., Pavletich N.P. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature. 401:1999;188-193
8. Gao L., Cueto M.A., Asselbergs F., Atadja P. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J. Biol. Chem. 277:2002;25748-25755
9. Glaser K.B., Staver M.J., Waring J.F., Stender J., Ulrich R.G., Davidsen S.K. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors. defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines Mol. Cancer Ther. 2:2003;151-163
10. Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer. an environment for comparative protein modeling Electrophoresis. 18:1997;2714-2723
11. Harding M.M. Metal ligand geometry relevant to proteins and in proteins. sodium and potassium Acta. Crystallogr. D Biol Crystallogr. 58:2002;872-874
12. Hassig C.A., Tong J.K., Fleischer T.C., Owa T., Grable P.G., Ayer D.E., Schreiber S.L. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc. Natl. Acad. Sci. USA. 95:1998;3519-3524
13. Hockly E., Richon V.M., Woodman B., Smith D.L., Zhou X., Rosa E., Sathasivam K., Ghazi-Noori S., Mahal A., Lowden P.A., et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA. 100:2003;2041-2046
14. Holm L., Sander C. The FSSP database of structurally aligned protein fold families. Nucleic Acids Res. 22:1994;3600-3609
15. Hu E., Chen Z., Fredrickson T., Zhu Y., Kirkpatrick R., Zhang G.F., Johanson K., Sung C.M., Liu R., Winkler J. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor. J. Biol. Chem. 275:2000;15254-15264
16. Johnstone R.W. Histone-deacetylase inhibitors. novel drugs for the treatment of cancer Nat. Rev. Drug Discov. 1:2002;287-289
17. Jung M., Brosch G., Kolle D., Scherf H., Gerhauser C., Loidl P. Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation. J. Med. Chem. 42:1999;4669-4679
18. Kabsch W., Sander C. Dictionary of protein secondary structure. pattern recognition of hydrogen-bonded and geometrical features Biopolymers. 22:1983;2577-2637
19. Kadosh D., Struhl K. Histone deacetylase activity of Rpd3 is important for transcriptional repression in vivo. Genes Dev. 12:1998;797-805
20. Kanyo Z.F., Scholnick L.R., Ash D.E., Christianson D.W. Structure of a unique binuclear manganese cluster in arginase. Nature. 383:1996;554-557
21. Khochbin S., Verdel A., Lemercier C., Seigneurin-Berny D. Functional significance of histone deacetylase diversity. Curr. Opin. Genet. Dev. 11:2001;162-166
22. Kissinger C.R., Gehlhaar D.K., Fogel D.B. Rapid automated molecular replacement by evolutionary search. Acta Crystallogr. D Biol Crystallogr. 55:1999;484-491
23. Kraulis P.J. Molscript. a program to produce both detailed and schematic plots of protein structures J. Appl. Crystallogr. 24:1991;946-950
24. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. Procheck. a program to check the stereochemical quality of protein structures J. Appl. Crystallogr. 26:1993;283-291
25. Lee H., Rezai-Zadeh N., Seto E. Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A. Mol. Cell. Biol. 24:2004;765-773
26. Marks P.A., Richon V.M., Breslow R., Rifkind R.A. Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol. 13:2001;477-483
27. Merritt E.A., Murphy M.E.P. Raster3D, version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 50:1994;869-873
28. Ng H.H., Bird A. Histone deacetylases. silencers for hire Trends Biochem. Sci. 25:2000;121-126
29. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276A:1997;307-326
30. Perrakis A., Sixma T.K., Wilson K.S., Lamzin V.S. Warp. improvement and extension of crystallographic phases by weighted averaging of multiple refined dummy atomic models Acta Crystallogr. D Biol. Crystallogr. 53:1997;448-455
31. Richon V.M., Emiliani S., Verdin E., Webb Y., Breslow R., Rifkind R.A., Marks P.A. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc. Natl. Acad. Sci. USA. 9:1998;3003-3007
32. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:1998;599-606
33. Thompson J.D., Higgins D.G., Gibson T.J. Clustal w. improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucleic Acids Res. 22:1994;4673-4680
34. Tsai S.C., Seto E. Regulation of histone deacetylase 2 by protein kinase CK2. J. Biol. Chem. 277:2002;31826-31833
35. Van den Wyngaert I., de Vries W., Kremer A., Neefs J., Verhasselt P., Luyten W.H., Kass S.U. Cloning and characterization of human histone deacetylase 8. FEBS Lett. 478:2000;77-83
36. Van Lint C., Emiliani S., Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 5:1996;245-253
37. Vigushin D.M., Coombes R.C. Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs. 13:2002;1-13
38. Witt, O., Monkemeyer, S., Ronndahl, G., Erdlenbruch, B., Reinhardt, D., Kanbach, K., and Pekrun, A. (2003). Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. Blood 101, 2001.
39. Yoshida M., Kijima M., Akita M., Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265:1990;17174-17179. a
40. Yoshida M., Hoshikawa Y., Koseki K., Mori K., Beppu T. Structural specificity for biological activity of trichostatin A, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in Friend leukemia cells. J. Antibiot. (Tokyo). 43:1990;1101-1106. b